专题:Psychedelics and Drug Studies

This cluster of papers explores the therapeutic potential of psychedelic therapy, particularly focusing on the use of substances like psilocybin and MDMA for the treatment of depression, anxiety, and substance dependence. The research delves into the neurobiology, serotonin receptors, and brain function underlying the effects of these psychedelics, as well as their ability to induce mystical experiences and promote long-lasting positive changes in psychological functioning.
最新文献
The NeuroExistential Four-Principle Recovery Program (NE-FPRP)

article Full Text OpenAlex

Higher THC Concentration Medicinal Cannabis Products Efficacy and Safety Considerations: A Rapid Review

article Full Text OpenAlex

Neural signaling mechanisms in depression: bridging classical monoamine hypotheses, animal models, and emerging antidepressant strategies

article Full Text OpenAlex

Psychedelic Therapy vs Antidepressants for the Treatment of Depression Under Equal Unblinding Conditions

article Full Text OpenAlex

Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression

article Full Text OpenAlex

Cannabis and Mental Health

article Full Text OpenAlex

CARE – A Retrospective, Dual-Cohort, 24-Week Real-World Study from the German Pain e-Registry on the Effectiveness and Safety of CBD-Dominant Oral Cannabis Extracts versus THC/Dronabinol in Older Patients with Chronic Pain

article Full Text OpenAlex

Safety and efficacy are hardly separable in psychedelic therapy: A mechanism-based critique

article Full Text OpenAlex

Effects of Psycho Education on Intention to Use Substances among Adolescents in some Selected Schools in Enugu State, Nigeria

article Full Text OpenAlex

Psychedelic-Related Psychosis: From Model Psychosis to Psychotherapy

book-chapter Full Text OpenAlex

近5年高被引文献
Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression

article Full Text OpenAlex 1034 FWCI178.5213

Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder

letter Full Text OpenAlex 631 FWCI110.7797

Novel and emerging treatments for major depression

review Full Text OpenAlex 545 FWCI85.7132

Single-Dose Psilocybin Treatment for Major Depressive Disorder

article Full Text OpenAlex 456 FWCI138.5694

Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors

article Full Text OpenAlex 439 FWCI133.4034

Increased global integration in the brain after psilocybin therapy for depression

article Full Text OpenAlex 423 FWCI76.0404

Psychedelics promote plasticity by directly binding to BDNF receptor TrkB

article Full Text OpenAlex 416 FWCI126.4141

Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up

article Full Text OpenAlex 403 FWCI73.1455

MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial

article Full Text OpenAlex 373 FWCI113.0655

Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial

article Full Text OpenAlex 336 FWCI60.0272